- In February 2025, BD has announced plans to separate its Biosciences and Diagnostic Solutions businesses to enhance strategic focus, drive growth, and unlock value. The move aims to create two independent entities, each better positioned to capitalize on their respective markets. This decision underscores BD's commitment to strengthening its leadership in healthcare innovation while optimizing operational efficiencies for long-term success.
- In November 2023, CooperCompanies has acquired select Cook Medical assets for USD 300 million, enhancing its women’s health and surgical portfolio under CooperSurgical. The deal includes products like the Bakri Balloon and Doppler monitors. Expected to boost revenue and earnings in 2024, the acquisition strengthens Cooper’s Asia-Pacific position in fertility and gynecologic healthcare
